Moledina Malik, Lee Vickie, Alnahrawy Ahmed, Fydanaki Ourania, George Nicole, Hubby Nour, Metcalf Daisy, Man Natalie, Guevara Gabriella, Feeney Claire, Akshikar Rashmi, Jain Rajni, Aziz Ahmad, Bravis Vassiliki, Meeran Karim
Oculoplastics and Adnexal Service, Western Eye Hospital, Imperial College NHS Foundation Trust, 53-173 Marylebone Rd, London, NW1 5QH, UK.
Imperial College Ophthalmology Research Group (ICORG), London, UK.
Thyroid Res. 2025 Jul 22;18(1):37. doi: 10.1186/s13044-025-00249-4.
Dysthyroid Optic Neuropathy (DON) is a sight-threatening complication of Thyroid Eye Disease (TED). This study aims to identify the risk and predictive factors for DON in a multi-ethnic TED cohort.
Retrospective, cohort study of consecutive TED patients attending a multidisciplinary service over an 11-year period. Consecutive patients aged over 18 years old with a minimum of 6 months follow-up post-diagnosis of TED were included. We compared those patients with DON and those without (no-DON) to determine which factors were more prevalent in patients with DON.
There were 26 and 516 consecutive patients with DON and no-DON. The DON prevalence in the cohort was 5.0%. The DON group had a Mean Age at TED Diagnosis (MATD) of 57.8 vs. 46.1 years in the no-DON group. The mean presenting CAS, TRAb and Gorman Diplopia Score (GDS) were significantly higher 3.73 ± 1.80, 2.76 ± 1.05 and 11.31 ± 11.90 vs. 0.54 ± 0.80, 0.48 ± 0.90 and 6.95 ± 9.22 in the DON compared to the no-DON group respectively (p = 0.00, p = 0.00 and p = 0.04). On multivariable regression, we found the following risk factors for developing DON (Odds Ratios): MATD ≥ 53 years (5.2 p = 0.00), presenting CAS ≥ 4 (P = 0.00), presenting GDS ≥ 3 (7.5 p = 0.00), diabetes (5.7 p = 0.00), and baseline TRAb ≥ 5.0 IU/L (2.9 p = 0.04).
Patients with diabetes, increased MATD, and high presenting CAS, GDS, and TRAb are at increased risk of developing DON in our cohort. Clinicians should be especially vigilant of the risk of sight-threatening complications in TED patients with more than one of the above risk factors.
甲状腺功能异常性视神经病变(DON)是甲状腺眼病(TED)的一种威胁视力的并发症。本研究旨在确定多民族TED队列中DON的风险和预测因素。
对在11年期间接受多学科服务的连续TED患者进行回顾性队列研究。纳入年龄在18岁以上、确诊TED后至少随访6个月的连续患者。我们比较了患有DON的患者和未患有DON的患者(非DON),以确定哪些因素在患有DON的患者中更普遍。
分别有26例和516例连续的DON患者和非DON患者。队列中DON的患病率为5.0%。DON组的TED诊断时平均年龄(MATD)为57.8岁,而非DON组为46.1岁。与非DON组相比,DON组的初始临床活动评分(CAS)、促甲状腺素受体抗体(TRAb)和戈尔曼复视评分(GDS)的平均值显著更高,分别为3.73±1.80、2.76±1.05和11.31±11.90,而非DON组分别为0.54±0.80、0.48±0.90和6.95±9.22(p = 0.00、p = 0.00和p = 0.04)。在多变量回归分析中,我们发现以下发生DON的风险因素(比值比):MATD≥53岁(5.2,p = 0.00)、初始CAS≥4(P = 0.00)、初始GDS≥3(7.5,p = 0.00)、糖尿病(5.7,p = 0.00)以及基线TRAb≥5.0 IU/L(2.9,p = 0.04)。
在我们的队列中,患有糖尿病、MATD增加以及初始CAS、GDS和TRAb较高的患者发生DON的风险增加。临床医生应特别警惕具有上述多种风险因素的TED患者发生威胁视力并发症的风险。